Institutional Career Development Core

机构职业发展核心的使命是培养、指导和发展下一代 技术熟练和多样化的研究人员进行高质量的临床和转化研究。拟议 机构职业发展核心（KL 2）计划将得到加强和扩大，并将成为一个主要的 为威尔康奈尔及其合作机构的临床和研究部门提供资源。重要的是我们的 CTSC（1.0）的KL 2毕业生为该领域做出了有影响力的贡献。KL 2计划已建立 提供新技术和新兴技术（如纳米技术，生物工程， 和生物医学3D打印），以及核心能力的培训。随着新扩大和新颖的 创新、企业家精神、团队科学和精准医疗等方面的举措， 技术熟练的科学家骨干及其团队，具有利用 有效的解决方案，以加快临床和翻译的连续性。此外，学者将被介绍 多样化的职业途径，包括非传统的经验，如小型休假或校外实习， 制药公司和政府机构。团队科学的增强为生物医学 未来的研究团队将被开发出来。此外，跨学科的方法，以激发兴趣， 创业将利用与凯文M.麦戈文家庭创业中心 发展。一年一度的校友职业小组，以具有谁已经去了成功的职业生涯， 在学术界，工业界或政府的研究;和“企业家在居住计划”，其中 成功的企业家将担任学者和学生的导师。举办的培训讲习班 由研究领域的专家指导，将为学员和导师提供现场指导， 还可以使用提供最佳辅导做法的在线课程。随着新扩大的举措， 创造力，创业精神，团队科学，精准医学和信息学，一个高技能的干部， 学者们将有能力通过创新和有影响力的解决方案来应对复杂的生物医学挑战。 在拟议的资助期间（CTSC 2.0），该计划将利用威尔康奈尔CTSC的优势， 与其合作伙伴，其资源和其他积极的合作者，使基础和临床研究人员， 实现成功的独立性，并为临床和翻译领域做出重大贡献 research.成功的方案将在整个反恐和安保服务中心网络提供。

The mission of the Institutional Career Development Core is to train, mentor, and develop the next generation of skilled and diverse researchers to conduct high-quality clinical and translational research. The proposed Institutional Career Development Core (KL2) program will be enhanced and expanded and will be a major resource for clinical and research departments across Weill Cornell and its partner institutes. Importantly, our KL2 graduates in CTSC (1.0) have made impactful contributions to the field. The KL2 Program has established a track record of providing training in new and emerging technologies (e.g. Nanotechnology, Bioengineering, and Biomedical 3D Printing) in addition to training in core competencies. With newly expanded and novel initiatives involving creativity, entrepreneurship, team science and precision medicine, we will equip a highly skilled cadre of scientists and their teams with the skills to tackle complex biomedical challenges using impactful solutions to accelerate the clinical and translational continuum. Further, Scholars will be introduced to diverse career pathways including non-traditional experiences such as mini-sabbaticals or externships in pharmaceutical companies and government agencies. An enhancement of Team science for the biomedical research teams of the future will be developed. Also, an interdisciplinary approach to spark interest in entrepreneurship will capitalize on collaborations with the Kevin M. McGovern Family Center for Venture Development.; an annual Alumni Career Panel to feature graduates who have gone on to successful careers in research in academia, industry, or government; and an “Entrepreneurs in Residence Program” where successful entrepreneurs will serve as mentors to the Scholars and students. Training workshops conducted by experts in the field of research mentoring will be offered on-site for both mentees and mentors with access also to an online curriculum offering best practices in mentoring. With newly expanded initiatives involving creativity, entrepreneurship, team science, precision medicine, and informatics, a highly skilled cadre of Scholars will be equipped to tackle the complex biomedical challenges with innovative and impactful solutions. In the proposed funding period (CTSC 2.0), the Program will leverage the strengths of Weill Cornell CTSC’s with its partners, its resources, and other active collaborators to enable basic and clinical investigators to achieve successful independence and make significant contributions to the field of Clinical and Translational research. The successful programs will be made available throughout the CTSC network.